Showing results (201-210 of 220) with videos related to
Sort By:
Pageof 22
JACC. Cardiooncology|January 13, 2025
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint InhibitorsFlorian Moik, Jakob M Riedl, Dominik Barth, et al.Oncoimmunology|September 19, 2017
Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinomaGeorgi Atanasov, Corinna Dietel, Linda Feldbrügge, et al.Cancers|April 27, 2024
Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020Dominik Dannehl, Alexandra von Au, Tobias Engler, et al.ESMO Open|May 11, 2026
Peripheral blood DNA methylation profile and immune checkpoint inhibitor response in cancer patientsM Kleinberger, V Sunder-Plassmann, A M Starzer, et al.Journal of Medical Systems|July 4, 2026
AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose systemJonas Freudenberg, Johannes Knitza, Niklas Gremke, et al.Geburtshilfe Und Frauenheilkunde|September 4, 2024
Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability - Real-World Data from German Breast CentersHenning Schäffler, Dorothee Jakob, Sophia Huesmann, et al.ESMO Open|April 18, 2024
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysisD Dannehl, D Jakob, F Mergel, et al.International Journal of Molecular Sciences|November 25, 2023
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer CentersHenning Schäffler, Franziska Mergel, Kerstin Pfister, et al.Psychological Medicine|April 21, 2016
Evaluation of the 'Jumping to conclusions' bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteriaF Rausch, S Eisenacher, H Elkin, et al.The Lancet. Psychiatry|March 11, 2022
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trialChristian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.Pageof 22